| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Trevi Therapeutics, Inc. (TRVI) has 2 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. TRVI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 375.0K | $6.94M | - | |
| Other | 26.1K | $482.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2019 | Makower Joshua | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +51.3% | |
| May 9, 2019 | Makhzoumi Mohamad56 | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +51.3% | |
| May 9, 2019 | Florence Anthony A. Jr.56 | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +51.3% | |
| May 9, 2019 | Chang Carmen47 | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +51.3% | |
| May 9, 2019 | Behbahani Ali47 | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +51.3% | |
| May 9, 2019 | Good Jennifer L | See Remarks | Buy | 11,250 | $10.00 | $112,500.00 | +5.8% | |
| May 9, 2019 | New Enterprise Associates 16, L.P. | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +51.3% | |
| May 9, 2019 | Omega Fund V, L.P.89 | 10% Owner | Buy | 481,000 | $10.00 | $4,810,000.00 | +82.6% | |
| May 9, 2019 | Mellon Family Investment Co V | 10% Owner | Buy | 100,000 | $10.00 | $1,000,000.00 | +40.5% | |
| May 9, 2019 | Heffernan Michael Thomas | Director | Buy | 2,500 | $10.00 | $25,000.00 | +64.9% |